slotkoers
Shenzhen S.E.
00:00:00 21-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
10,7
CNY
|
+1,42%
|
|
-3,25%
|
-15,88%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
7.379
|
6.637
|
8.188
|
9.948
|
10.952
|
9.213
|
-
|
-
|
Bedrijfswaarde
1 |
7.379
|
6.637
|
8.188
|
9.948
|
10.952
|
9.213
|
9.213
|
9.213
|
K/w-verhouding
|
14,7
x
|
10,1
x
|
12,7
x
|
16,7
x
|
17,7
x
|
13,7
x
|
11,4
x
|
9,67
x
|
Dividendrendement
|
3,26%
|
3,52%
|
-
|
-
|
2,36%
|
2,99%
|
1,68%
|
4,3%
|
Marktkapitalisatie/omzet
|
2,02
x
|
2,04
x
|
-
|
-
|
2,74
x
|
2,09
x
|
1,83
x
|
1,62
x
|
Bedrijfswaarde/omzet
|
2,02
x
|
2,04
x
|
-
|
-
|
2,74
x
|
2,09
x
|
1,83
x
|
1,62
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
12,6
x
|
7,21
x
|
7,1
x
|
5,34
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2,11
x
|
1,79
x
|
-
|
-
|
1,99
x
|
1,56
x
|
1,39
x
|
1,29
x
|
Aantal aandelen (in duizenden)
|
824.515
|
801.278
|
861.029
|
816.739
|
861.029
|
861.029
|
-
|
-
|
Referentieprijs
2 |
8,950
|
8,283
|
9,510
|
12,18
|
12,72
|
10,70
|
10,70
|
10,70
|
Datum van publicatie
|
26-02-20
|
26-02-21
|
25-02-22
|
27-02-23
|
29-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
3.647
|
3.260
|
-
|
-
|
3.999
|
4.408
|
5.028
|
5.679
|
EBITDA
1 |
-
|
-
|
-
|
-
|
871,6
|
1.278
|
1.297
|
1.724
|
Bedrijfsresultaat (EBIT)
1 |
602,1
|
759,3
|
-
|
-
|
714,1
|
781,3
|
930,8
|
1.098
|
Operationele Marge
|
16,51%
|
23,29%
|
-
|
-
|
17,86%
|
17,73%
|
18,51%
|
19,33%
|
Resultaat voor belastingen (EBT)
1 |
603,4
|
753
|
-
|
-
|
708
|
777,7
|
927,2
|
1.093
|
Nettowinst (verlies)
1 |
520,4
|
653,5
|
614
|
646,4
|
618,9
|
672,6
|
809,1
|
951
|
Nettomarge
|
14,27%
|
20,04%
|
-
|
-
|
15,48%
|
15,26%
|
16,09%
|
16,74%
|
WPA
2 |
0,6075
|
0,8175
|
0,7500
|
0,7300
|
0,7200
|
0,7800
|
0,9375
|
1,107
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,2917
|
0,2917
|
-
|
-
|
0,3000
|
0,3200
|
0,1800
|
0,4600
|
Datum van publicatie
|
26-02-20
|
26-02-21
|
25-02-22
|
27-02-23
|
29-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
14,4%
|
17,4%
|
14,2%
|
-
|
11,7%
|
11,4%
|
12,2%
|
13,3%
|
ROA (netto-inkomsten/totale activa)
|
9,78%
|
11,6%
|
-
|
-
|
8,06%
|
7,8%
|
8,65%
|
9,8%
|
Totale activa
1 |
5.322
|
5.649
|
-
|
-
|
7.675
|
8.623
|
9.354
|
9.704
|
Nettoactief per aandeel
2 |
4,250
|
4,630
|
-
|
-
|
6,400
|
6,880
|
7,710
|
8,270
|
Cashflow per aandeel
2 |
0,6200
|
0,6100
|
-
|
-
|
0,9200
|
1,000
|
1,170
|
1,470
|
Capex
1 |
335
|
332
|
-
|
-
|
-
|
375
|
375
|
375
|
Capex/omzet
|
9,19%
|
10,17%
|
-
|
-
|
-
|
8,51%
|
7,46%
|
6,6%
|
Datum van publicatie
|
26-02-20
|
26-02-21
|
25-02-22
|
27-02-23
|
29-03-24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -15,88% | 1,27 mld. | | +51,63% | 796 mld. | | +41,51% | 628 mld. | | -5,10% | 358 mld. | | +19,90% | 331 mld. | | +9,95% | 301 mld. | | +17,66% | 244 mld. | | +3,39% | 228 mld. | | +10,75% | 214 mld. | | +6,99% | 165 mld. |
Farmaceutische producten - Andere
|